A detailed history of Bvf Inc transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Bvf Inc holds 441,528 shares of JANX stock, worth $24 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
441,528
Previous 2,919,818 84.88%
Holding current value
$24 Million
Previous $110 Million 83.18%
% of portfolio
0.57%
Previous 3.29%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$35.12 - $64.78 $87 Million - $161 Million
-2,478,290 Reduced 84.88%
441,528 $18.5 Million
Q1 2024

May 15, 2024

SELL
$7.93 - $49.75 $13.2 Million - $82.6 Million
-1,660,000 Reduced 36.25%
2,919,818 $110 Million
Q3 2023

Nov 14, 2023

BUY
$9.56 - $14.0 $4.52 Million - $6.62 Million
472,873 Added 11.51%
4,579,818 $46.2 Million
Q2 2023

Aug 14, 2023

BUY
$11.08 - $15.92 $27.9 Million - $40.1 Million
2,521,268 Added 159.0%
4,106,945 $48.7 Million
Q1 2023

May 15, 2023

BUY
$11.25 - $22.21 $1.3 Million - $2.56 Million
115,343 Added 7.84%
1,585,677 $19.2 Million
Q2 2022

Aug 15, 2022

BUY
$9.52 - $15.65 $3.12 Million - $5.13 Million
327,994 Added 28.71%
1,470,334 $18 Million
Q1 2022

May 16, 2022

BUY
$13.24 - $20.24 $1.66 Million - $2.53 Million
125,026 Added 12.29%
1,142,340 $16.4 Million
Q3 2021

Nov 15, 2021

SELL
$20.7 - $34.69 $3.3 Million - $5.53 Million
-159,367 Reduced 13.54%
1,017,314 $22 Million
Q2 2021

Aug 16, 2021

BUY
$18.58 - $25.37 $21.9 Million - $29.9 Million
1,176,681 New
1,176,681 $29.4 Million

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $2.27B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.